Dr. Mierzwa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Drive
B2 Floor University Hospital Rm C490
Ann Arbor, MI 48109Phone+1 513-584-3494
Education & Training
University of Cincinnati Medical Center/College of MedicineResidency, Radiation Oncology, 2004 - 2008
Christ HospitalInternship, Internal Medicine, 2003 - 2004
University of Cincinnati College of MedicineClass of 2003
Certifications & Licensure
MI State Medical License 2008 - 2025
OH State Medical License 2003 - 2016- American Board of Radiology Radiation Oncology
Clinical Trials
- Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer Start of enrollment: 2019 Sep 05
Roles: Contact, Principal Investigator
- Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer Start of enrollment: 2023 Dec 20
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Interpretable survival network for progression risk analysis of multimodality imaging biomarkers in poor-prognosis head and neck cancers.Lise Wei, Madhava P Aryal, Choonik Lee, Jennifer L Shah, Michelle L Mierzwa
Scientific Reports. 2024-12-03 - 1 citationsFollow-up for human papillomavirus-related oropharynx cancer concentrated on unequal symptom change (FOCUS): Prospective patient-reported outcome collection.Donna M Edwards, Laila A Gharzai, Weilin Wang, Charles Mayo, Krithika Suresh
Head & Neck. 2024-11-01 - Quality and Safety Considerations for Adaptive Radiation Therapy: An ASTRO White Paper.Indrin J Chetty, Bin Cai, Michael D Chuong, Samantha L Dawes, William A Hall
International Journal of Radiation Oncology, Biology, Physics. 2024-10-16
Press Mentions
Naveris to Showcase Advances in Precision Surveillance for HPV-Associated Oropharyngeal Cancer Using the NavDx® Test at the 2024 ASTRO Annual MeetingSeptember 28th, 2024- Ann Arbor Medical and Mental Health Doctors Want Date for in-Person School Learning OptionFebruary 8th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
